Whether progesterone can help with blood sugar is not scientifically settled. Mechanistic evidence suggests that progesterone receptors are present on pancreatic beta cells and in adipose tissue, and the hormone may modulate insulin secretion and sensitivity. Some studies indicate a blood sugar-lowering effect, while others point to possible impairment of glucose tolerance, especially with high-dose or synthetic progestins used in hormone replacement therapy. However, the evidence base is weak, relying mostly on animal experiments and small human trials. For menopausal women using progesterone as part of hormone therapy, the impact on blood glucose is usually minor and not clinically significant. In individuals with diabetes or prediabetes, progesterone use should be medically supervised. Progesterone is not indicated as a blood sugar-lowering agent and is not recommended by clinical guidelines. Genetic variants in hormone receptor genes might theoretically influence the effect, but no validated tests exist. In summary: progesterone has a plausible but unproven role in glucose metabolism; current evidence does not support its use for glycemic control.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-78b65ef9a328d5d2da10fb31